Kymera files Form 144 to sell 11,611 shares

Kymera Therapeutics, Inc. filed a Form 144 to sell shares on 04/09/2026.

Rhea-AI Filing Summary

Kymera Therapeutics, Inc. filed a Form 144 to sell shares on 04/09/2026. The notice lists 9,111 shares described as shares acquired upon vesting of Restricted Stock Units under the 2020 Equity Incentive Plan and 2,500 shares from exercise of stock options; sales are through Morgan Stanley Smith Barney LLC.

Insights

Equity Compensation Analyst

Form 144 lists proposed resale of vested RSUs and exercised-option shares.

The filing identifies 9,111 shares from vested Restricted Stock Units and 2,500 shares from option exercise, both dated 04/09/2026. The broker listed is Morgan Stanley Smith Barney LLC.

These are routine resale notices for insider-held compensation shares; timing and sale mechanics follow broker-assisted resale procedures in the notice.

Key Figures

RSU shares to be sold: 9,111 shares Option exercise shares: 2,500 shares Broker: Morgan Stanley Smith Barney LLC +1 more

4 metrics

RSU shares to be sold 9,111 shares Shares acquired upon vesting under the 2020 Equity Incentive Plan (04/09/2026)

Option exercise shares 2,500 shares Shares from exercise of stock options (04/09/2026)

Broker Morgan Stanley Smith Barney LLC Broker listed for resale transactions (address: 1 New York Plaza)

Form type date 04/09/2026 Date shown for securities to be sold

Key Terms

Restricted Stock Units, Form 144, Equity compensation

3 terms

Restricted Stock Units financial

"Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Equity compensation financial

"Equity compensation Common Stock | 04/09/2026 | Exercise of Stock Options"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KYMR Form 144 filed on 04/09/2026 disclose?

It discloses a proposed sale of 9,111 shares from vested RSUs and 2,500 shares from an option exercise. The sales are to be executed through Morgan Stanley Smith Barney LLC on 04/09/2026.

Who is the broker handling the KYMR resale under Form 144?

The listed broker is Morgan Stanley Smith Barney LLC located at 1 New York Plaza, New York. The notice indicates broker-assisted resale as the planned distribution channel on 04/09/2026.

Are the shares in KYMR Form 144 from compensation or open-market purchases?

The filing states 9,111 shares were acquired upon vesting of Restricted Stock Units under the 2020 Equity Incentive Plan and 2,500 shares were from option exercise. These are compensation-related sources.

Does KYMR Form 144 state when the sales will occur?

The Form 144 entry lists the date 04/09/2026 for the securities to be sold. Further timing and execution details beyond that date are not provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/09/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002060075
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KYMERA THERAPEUTICS, INC.
SEC File Number	001-39460
Address of Issuer	500 North Beacon Street 4th Floor Watertown MASSACHUSETTS 02472
Phone	(857)-285-5300
Name of Person for Whose Account the Securities are To Be Sold	Noah Goodman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 38th Floor New York NY 10004	11611	1014221	81642394	04/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/09/2026	Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.	KYMERA THERAPEUTICS, INC.			9111	04/09/2026	Equity compensation
Common Stock	04/09/2026	Exercise of Stock Options	KYMERA THERAPEUTICS, INC.			2500	04/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units on 4/8/2026 or were received upon the exercise of stock options. The dates of acquisition and payment were and will be the dates of exercise/sale. Certain sales reported on this Form 144 represent shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are automatic and intended to qualify under Rule 10b5-1. Other sales are pursuant to a 10b5-1 plan entered into on December 10, 2025.
Date of Notice	04/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Bruce Jacobs
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)